Literature DB >> 26728149

Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity.

J Gavin Daigle1,2, Karthik Krishnamurthy3, Nandini Ramesh2,4, Ian Casci2,4, John Monaghan2, Kevin McAvoy3, Earl W Godfrey5, Dianne C Daniel6, Edward M Johnson6, Zachary Monahan7, Frank Shewmaker7, Piera Pasinelli3, Udai Bhan Pandey8,9,10.   

Abstract

Amyotrophic lateral sclerosis is characterized by progressive loss of motor neurons in the brain and spinal cord. Mutations in several genes, including FUS, TDP43, Matrin 3, hnRNPA2 and other RNA-binding proteins, have been linked to ALS pathology. Recently, Pur-alpha, a DNA/RNA-binding protein was found to bind to C9orf72 repeat expansions and could possibly play a role in the pathogenesis of ALS. When overexpressed, Pur-alpha mitigates toxicities associated with Fragile X tumor ataxia syndrome (FXTAS) and C9orf72 repeat expansion diseases in Drosophila and mammalian cell culture models. However, the function of Pur-alpha in regulating ALS pathogenesis has not been fully understood. We identified Pur-alpha as a novel component of cytoplasmic stress granules (SGs) in ALS patient cells carrying disease-causing mutations in FUS. When cells were challenged with stress, we observed that Pur-alpha co-localized with mutant FUS in ALS patient cells and became trapped in constitutive SGs. We also found that FUS physically interacted with Pur-alpha in mammalian neuronal cells. Interestingly, shRNA-mediated knock down of endogenous Pur-alpha significantly reduced formation of cytoplasmic stress granules in mammalian cells suggesting that Pur-alpha is essential for the formation of SGs. Furthermore, ectopic expression of Pur-alpha blocked cytoplasmic mislocalization of mutant FUS and strongly suppressed toxicity associated with mutant FUS expression in primary motor neurons. Our data emphasizes the importance of stress granules in ALS pathogenesis and identifies Pur-alpha as a novel regulator of SG dynamics.

Entities:  

Keywords:  ALS; Amyotrophic lateral sclerosis; C9orf72; FUS; Motor neuron diseases; Neurodegeneration; Primary motor neurons; Pur-alpha; RNA-binding proteins; Stress granules; TDP-43

Mesh:

Substances:

Year:  2016        PMID: 26728149      PMCID: PMC4791193          DOI: 10.1007/s00401-015-1530-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  77 in total

1.  Stress granule assembly is mediated by prion-like aggregation of TIA-1.

Authors:  Natalie Gilks; Nancy Kedersha; Maranatha Ayodele; Lily Shen; Georg Stoecklin; Laura M Dember; Paul Anderson
Journal:  Mol Biol Cell       Date:  2004-09-15       Impact factor: 4.138

2.  Concomitant translocation of Puralpha with its binding proteins (PurBPs) from nuclei to cytoplasm during neuronal development.

Authors:  Ling-Hui Zeng; Ko Okamura; Hidekazu Tanaka; Naomasa Miki; Che-Hui Kuo
Journal:  Neurosci Res       Date:  2005-01       Impact factor: 3.304

Review 3.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

4.  Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.

Authors:  Sami J Barmada; Gaia Skibinski; Erica Korb; Elizabeth J Rao; Jane Y Wu; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

5.  Pathological stress granules in Alzheimer's disease.

Authors:  Peter E A Ash; Tara E Vanderweyde; Katherine L Youmans; Daniel J Apicco; Benjamin Wolozin
Journal:  Brain Res       Date:  2014-08-07       Impact factor: 3.252

6.  Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration.

Authors:  Zihui Xu; Mickael Poidevin; Xuekun Li; Yujing Li; Liqi Shu; David L Nelson; He Li; Chadwick M Hales; Marla Gearing; Thomas S Wingo; Peng Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-03       Impact factor: 11.205

7.  Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.

Authors:  Peng Jin; Ranhui Duan; Abrar Qurashi; Yunlong Qin; Donghua Tian; Tracie C Rosser; Huijie Liu; Yue Feng; Stephen T Warren
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

8.  RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules.

Authors:  N L Kedersha; M Gupta; W Li; I Miller; P Anderson
Journal:  J Cell Biol       Date:  1999-12-27       Impact factor: 10.539

9.  Studies of alternative isoforms provide insight into TDP-43 autoregulation and pathogenesis.

Authors:  Simon D'Alton; Marcelle Altshuler; Jada Lewis
Journal:  RNA       Date:  2015-06-18       Impact factor: 4.942

10.  Pur-alpha functionally interacts with FUS carrying ALS-associated mutations.

Authors:  M Di Salvio; V Piccinni; V Gerbino; F Mantoni; S Camerini; J Lenzi; A Rosa; L Chellini; F Loreni; M T Carrì; I Bozzoni; M Cozzolino; G Cestra
Journal:  Cell Death Dis       Date:  2015-10-22       Impact factor: 8.469

View more
  26 in total

Review 1.  Age-related neurodegenerative diseases.

Authors:  Michael Duggan; Bahareh Torkzaban; Taha Mohseni Ahooyi; Kamel Khalili; Jennifer Gordon
Journal:  J Cell Physiol       Date:  2019-09-25       Impact factor: 6.384

2.  Potentiating Hsp104 activity via phosphomimetic mutations in the middle domain.

Authors:  Amber Tariq; JiaBei Lin; Megan M Noll; Mariana P Torrente; Korrie L Mack; Oscar Hernandez Murillo; Meredith E Jackrel; James Shorter
Journal:  FEMS Yeast Res       Date:  2018-08-01       Impact factor: 2.796

Review 3.  PURA, the gene encoding Pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functions.

Authors:  Dianne C Daniel; Edward M Johnson
Journal:  Gene       Date:  2017-12-06       Impact factor: 3.688

4.  A synthetic Pur-based peptide binds and alters G-quadruplex secondary structure present in the expanded RNA repeat of C9orf72 ALS/FTD.

Authors:  Margaret J Wortman; Ayuna V Dagdanova; Andrea M Clark; Earl W Godfrey; Steven M Pascal; Edward M Johnson; Dianne C Daniel
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-02-06       Impact factor: 4.739

5.  Memory deficits, gait ataxia and neuronal loss in the hippocampus and cerebellum in mice that are heterozygous for Pur-alpha.

Authors:  Mary F Barbe; Jessica J Krueger; Regina Loomis; Jessica Otte; Jennifer Gordon
Journal:  Neuroscience       Date:  2016-09-17       Impact factor: 3.590

Review 6.  Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.

Authors:  Alexander Starr; Rita Sattler
Journal:  Brain Res       Date:  2018-02-14       Impact factor: 3.252

Review 7.  Stress granules at the intersection of autophagy and ALS.

Authors:  Zachary Monahan; Frank Shewmaker; Udai Bhan Pandey
Journal:  Brain Res       Date:  2016-05-13       Impact factor: 3.252

Review 8.  The roles of intrinsic disorder-based liquid-liquid phase transitions in the "Dr. Jekyll-Mr. Hyde" behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Authors:  Vladimir N Uversky
Journal:  Autophagy       Date:  2017-12-17       Impact factor: 16.016

Review 9.  Fly for ALS: Drosophila modeling on the route to amyotrophic lateral sclerosis modifiers.

Authors:  Francesco Liguori; Susanna Amadio; Cinzia Volonté
Journal:  Cell Mol Life Sci       Date:  2021-07-28       Impact factor: 9.261

Review 10.  C9orf72-mediated ALS and FTD: multiple pathways to disease.

Authors:  Rubika Balendra; Adrian M Isaacs
Journal:  Nat Rev Neurol       Date:  2018-09       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.